Who are the key players in North America CRISPR Market industry?

The top five key players in the North America CRISPR market include Thermo Fisher Scientific, Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, and Agilent Technologies. These companies are leading in CRISPR product innovation, research partnerships, and therapeutic applications, pushing boundaries across biotechnology, healthcare, and agricultural sectors.

What is the North America CRISPR Market growth?

The North America CRISPR market has experienced robust growth, with a CAGR of over 18% in recent years. Companies like Editas Medicine have contributed to growth through strategic collaborations and breakthroughs in gene-editing therapies, thus expanding the market's scope and investment.

Which segment accounted for the largest North America CRISPR Market share?

The biomedical applications segment holds the largest market share within the North America CRISPR market. This is attributed to the increased adoption of CRISPR technology in gene therapy, drug discovery, and disease treatment, with companies such as CRISPR Therapeutics driving innovation in genetic medicine.

What are the factors driving the North America CRISPR Market?

Key driving factors include rising investment in biomedical research, advances in gene editing technologies, and supportive regulatory environments. For example, Thermo Fisher Scientific’s enhanced CRISPR portfolios and partnerships with research institutions have accelerated the adoption of CRISPR-based tools in various fields.

Which type accounted for the largest North America CRISPR Market share?

By type, the CRISPR/Cas9 system dominates the North America CRISPR market owing to its versatility, cost-effectiveness, and high efficiency. Agilent Technologies and others extensively utilize CRISPR/Cas9 for genetic research, genome editing, and development of novel biotech solutions, consolidating its leading position.

Home Healthcare

North America CRISPR Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

Name: North America CRISPR Market
Brand: Bussiness Insights

North America CRISPR Market: by Type (Gene Editing, Gene Regulation, Genetic Engineering, Genomic Imaging, CRISPR Diagnostics, Others), Application (Biomedical, Agriculture, Industrial, Research and Development, Drug Discovery, Others), Distribution Channels (Direct Sales, Distributors, Online, Retail, Wholesale, Others), Technology (Zinc Finger Nucleases, TALEN, CRISPR/Cas9, MegaTALs, Others), Organization Size (Small, Medium, Large) and By North America Historical & Forecast Period (2020-2035) Comprehensive Study 2025

Last Updated: 31-07-2025 | Format: PDF | Report ID:20372 | Author: Raj K

RD TOC Segmentation Research Methodology Request For Free Sample

North America CRISPR Market Insights and Forecast (2025-2035)

The North America CRISPR market is transforming genomic research and therapies, leveraging breakthroughs across biomedical, agriculture, and diagnostics sectors. With surging demand from gene editing, precision medicine, and biotechnological advancement, the sector is witnessing robust growth led by both established players and innovative startups. CRISPR's applications in disease modeling, crop improvement, and pharmaceutical discovery amplify its role as a critical pillar in North America’s biotech ecosystem.

Latest Market Dynamics

Key Drivers

Rising investment in gene therapies by major biotech firms and healthcare providers, fueled by the FDA’s positive stance towards CRISPR-based clinical trials. For instance, in 2025, CRISPR Therapeutics partnered with Vertex Pharma for late-stage clinical trials of gene-editing therapies.

Expansion of CRISPR-based diagnostics, as evidenced by industry launches like Synthego’s new CRISPR-based pathogen detection kits (Q1 2025), supporting rapid infectious disease screening.
Growing use of CRISPR for gene regulation and epigenetic editing, with Editas Medicine advancing research collaborations for precise gene expression modulation.

Emergence of adoptive cell therapies and in vivo gene editing, allowing companies like Intellia Therapeutics to accelerate next-generation therapeutic pipelines.
Increasing collaboration between academia and industry to commercialize CRISPR research, such as agreements between Thermo Fisher Scientific and North American universities for R&D project acceleration.

Gene Editing dominates the North America CRISPR market, capturing over half of total market share in 2025, driven by its core role in therapeutic development and plant biotechnology. CRISPR Diagnostics and Genomic Imaging are rapidly expanding, reflecting increased demand for high-throughput disease detection and real-time cellular biology applications. Other types, including gene regulation and novel engineering applications, establish a strong presence through targeted innovation and niche solutions.

The biomedical sector remains the leading application area for CRISPR in North America, accounting for more than half the total market share in 2025. Agriculture is the next significant sector, with gene-editing tools providing breakthroughs in crop efficiency and quality. Industrial and R&D applications continue to grow, supporting product optimization and fundamental research throughout the region.

The North America CRISPR market revenue exhibits strong upward momentum, growing from $350 Million in 2020 to a projected $2,870 Million by 2035. Patient adoption, investment, and expanding clinical indications drive this robust trend, with acceleration expected in late 2020s as regulatory clarity and public acceptance improve. The compound annual growth rate underlines the transformative potential and widespread adoption of CRISPR technologies across biomedical, agricultural, and diagnostics industries.

Year-on-year growth rates reflect continued momentum for the North America CRISPR market. The initial CAGR of 18% in the early 2020s peaks at 22% by 2025, before gradually normalizing as the market matures. Expansion in diagnostics and the entry of new clinical products sustain above-average growth for the forecast period. Regulatory adaptation and broadening applications maintain these positive annual growth trends.

The United States holds the largest regional share, representing more than three-quarters of the North American CRISPR market in 2025, attributable to the presence of major research hubs and leading firms. Canada accounts for a moderate portion, followed by Mexico, where increased investment in biotech innovation is accelerating CRISPR market penetration across agricultural and pharmaceutical sectors.

Top firms such as CRISPR Therapeutics and Editas Medicine command significant CRISPR market share in North America due to advanced pipelines and strong funding. The leading five companies collectively account for over two-thirds of the market, with newer entrants and diversified technology providers steadily capturing the remainder through innovation and collaborative deals.

Metrics	Details
Years	2020-2035
Base Year	2025
Market Size	850
Regions	US, Canada, Mexico
Segments	Gene Editing, Gene Regulation, Genetic Engineering, Genomic Imaging, CRISPR Diagnostics, Others, Biomedical, Agriculture, Industrial, Research and Development, Drug Discovery, Others, Zinc Finger Nucleases, TALEN, CRISPR/Cas9, MegaTALs, Others, Direct Sales, Distributors, Online, Retail, Wholesale, Others, Small, Medium, Large
Players	CRISPR Therapeutics, Editas Medicine, Intellia Therapeutics, Caribou Biosciences, Thermo Fisher Scientific, Synthego Corporation, Merck KGaA, Agilent Technologies, GenScript, Horizon Discovery, Danaher Corporation, Precision Biosciences, Beam Therapeutics, ToolGen, Cellectis

June 2024: CRISPR Therapeutics and Vertex Pharmaceuticals announce positive results in late-phase sickle cell trial, advancing regulatory submission plans.
July 2024: Synthego launches cloud-based CRISPR software for improved guide RNA efficacy, targeting both researchers and industrial biotech clients.
August 2024: Editas Medicine enters strategic partnership with Emory University for targeted gene editing in rare ocular diseases.
September 2024: Thermo Fisher Scientific expands CRISPR reagent production capacity in New Jersey, addressing supply chain bottlenecks.
October 2024: Caribou Biosciences acquires AI genomics startup to enhance in-house drug discovery platforms.

About the Author

Raj K

Senior Market Research Analyst

Raj K is a Senior Market Research Analyst specializing in market research, industry analysis, and business consulting across Healthcare. Raj K brings a commercially grounded perspective to sectors shaped by changing demand, innovation, and competitive dynamics, helping turn complex market trends into clear strategic insights for business decision-makers. With 10+ years of experience across research, analytics, and strategic advisory roles, Raj K has helped organizations translate data into actionable growth strategies.

HealthcareMarket ResearchIndustry AnalysisStrategic Consulting

Key Questions Answered

»What is the market size and growth rate of the global and regional market by various segments?
»What is the market size and growth rate of the market for selective countries?
»Which region or sub-segment is expected to drive the market in the forecast period?
»What factors are estimated to drive and restrain the market growth?
»What are the key technological and market trends shaping the market?
»What are the key opportunities in the market?
»What are the key companies operating in the market?
»Which company accounted for the highest market share?

Download Sample

Why Choose Bussiness Insights?

»Strong Industry Focus
»Extensive Product Offerings
»Customer Research Services
»Robust Research Methodology
»Comprehensive Reports
»Latest Technological Developments
»Value Chain Analysis
»Potential Market Opportunities
»Growth Dynamics
»Quality Assurance
»Post-sales Support
»Regular Report Updates

Speak to Analyst

North America CRISPR Market Size & Share Analysis - Growth Trends and Forecast (2026 - 2035)

North America CRISPR Market Insights and Forecast (2025-2035)

Latest Market Dynamics

Key Drivers

Key Trends

Key Opportunities

Key Challenges

Key Restraints

CRISPR Market Share by Type, 2025

CRISPR Market Share by Applications, 2025

CRISPR Market Revenue in North America (2020-2035)

Year-on-Year Market Growth (%) in North America CRISPR Market (2020-2035)

CRISPR Market Share by Region, 2025 (North America)

Market Share by Leading Players, 2025

CRISPR Market Buyer Share, 2025

Study Coverage

Key Recent Developments

Frequently Asked Questions

About the Author

Related Reports